首页> 外文期刊>Current Pharmacogenomics >DNA Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy
【24h】

DNA Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy

机译:基于DNA芯片的基因表达谱分析在癌症中的作用:帮助癌症诊断,评估预后并预测对治疗的反应

获取原文
获取原文并翻译 | 示例
           

摘要

A DNA microarray is a solid support such as a glass slide, silicon chip or nylon membrane on which DNA molecules are attached at precise locations. Using DNA microarrays, the expression of tens of thousands of genes in a biological sample can be detected in one experiment. Emerging data suggests that the use of DNA microarrays can aid the differentiation of tumors with similar morphological appearance, predict patient outcome independently of conventional prognostic factors and select for response or resistance to specific anti-cancer therapies. DNA microarray technology thus has the potential to supplement standard diagnostic procedures in oncology and permit a more individualized approach to patient management. Prior to clinical application, however, this methodology must be simplified, standardized, evaluated in external quality assessment schemes and made available at relatively low costs. Most importantly, the preliminary, but promising, early findings must be validated by high-level evidence studies, such as large prospective randomized trials or meta-analyses.
机译:DNA微阵列是固体支持物,例如载玻片,硅片或尼龙膜,其上的DNA分子附着在精确的位置。使用DNA微阵列,可以在一个实验中检测生物样品中成千上万个基因的表达。新兴数据表明,DNA微阵列的使用可以帮助分化具有相似形态学外观的肿瘤,独立于常规预后因素预测患者预后,并选择对特定抗癌疗法的反应或耐药性。因此,DNA微阵列技术有可能补充肿瘤学中的标准诊断程序,并允许采用更具个性化的方法进行患者管理。但是,在临床应用之前,必须对这种方法进行简化,标准化,在外部质量评估方案中进行评估并以相对较低的成本提供。最重要的是,必须通过高级证据研究(例如大型前瞻性随机试验或荟萃分析)来验证初步但有希望的早期发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号